trial · primary record
B7-H3-targeting CAR-T cells/TX103-CAR-T Cell Injection
Glioblastoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Incidence of Dose Limiting Toxicity (DLT) |
| Registry ID | NCT05241392 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:09.170Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05241392
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.